IRIS
CURATOLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 62.688
EU - Europa 3.896
AS - Asia 1.023
SA - Sud America 32
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
Totale 67.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 62.639
UA - Ucraina 849
DE - Germania 684
IE - Irlanda 660
CN - Cina 466
IT - Italia 447
FR - Francia 312
KR - Corea 288
GB - Regno Unito 248
FI - Finlandia 189
PL - Polonia 158
SE - Svezia 106
RU - Federazione Russa 84
JP - Giappone 50
NL - Olanda 43
TW - Taiwan 43
CA - Canada 34
IN - India 30
BE - Belgio 26
TR - Turchia 25
ES - Italia 22
HK - Hong Kong 19
ID - Indonesia 15
MX - Messico 15
PT - Portogallo 14
AU - Australia 13
GR - Grecia 13
RO - Romania 13
SG - Singapore 11
BR - Brasile 10
IL - Israele 8
IQ - Iraq 8
MY - Malesia 8
VN - Vietnam 8
CH - Svizzera 7
CL - Cile 7
EC - Ecuador 7
IR - Iran 7
EU - Europa 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 5
PE - Perù 5
HU - Ungheria 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
EG - Egitto 3
KW - Kuwait 3
NO - Norvegia 3
PH - Filippine 3
SA - Arabia Saudita 3
AM - Armenia 2
DK - Danimarca 2
ET - Etiopia 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
SM - San Marino 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
SI - Slovenia 1
Totale 67.673
Salva come PNG Salva come JPEG
Città #
Woodbridge 19.260
Wilmington 17.591
Houston 14.553
Fairfield 2.385
Ann Arbor 1.524
Ashburn 970
Seattle 892
Chandler 852
Cambridge 845
Jacksonville 738
Dublin 622
Medford 490
Dearborn 439
Beijing 267
Lawrence 233
Kraków 155
New York 145
Rome 140
San Diego 110
Menlo Park 102
Norwalk 97
Mülheim 87
Milan 49
Redwood City 47
Taipei 40
University Park 38
Zhengzhou 36
London 34
Verona 31
Falls Church 28
Saint Petersburg 26
Mountain View 25
Nanjing 25
San Mateo 20
Seoul 19
Toronto 19
Brussels 16
Kunming 16
Boardman 15
Detroit 14
Hefei 14
Nürnberg 13
Guangzhou 12
Konya 12
Phoenix 12
Redmond 12
Creede 11
Helsinki 11
Hong Kong 11
Xalapa 11
Nanchang 10
Palo Alto 10
Shanghai 10
Athens 9
Bari 9
Del Norte 9
Lappeenranta 9
Wuhan 9
Indiana 8
Los Angeles 8
San Francisco 8
Chicago 7
Jinan 7
Laguna Niguel 7
Lisbon 7
Southall 7
Council Bluffs 6
Hounslow 6
Kuala Lumpur 6
Quito 6
Ankara 5
Chennai 5
Chiswick 5
Kilburn 5
Munich 5
New Bedfont 5
Parma 5
Santa Clara 5
Waanrode 5
Zaragoza 5
Busto Arsizio 4
Dong Ket 4
Dronten 4
Hanoi 4
Hyderabad 4
Islington 4
Madrid 4
Nashville 4
Paris 4
Pavullo Nel Frignano 4
Pune 4
Salt Lake City 4
Semarang 4
Shenyang 4
Singapore 4
Suceava 4
São Paulo 4
Auburn Hills 3
Auckland 3
Baotou 3
Totale 63.399
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 475
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study 443
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 428
Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders 418
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. 416
Human endogenous retroviruses and ADHD 416
Association study of autistic disorder and chromosome 16p 414
Impairment in flexible regulation of speed and accuracy in children with ADHD 414
ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? 412
Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes 410
Tourette syndrome and comorbid ADHD: causes and consequences 410
Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders 409
Association between presenilin-1 -48C/T polymorphism and Down's syndrome 406
mTOR Inhibitors in Tuberous Sclerosis Complex. 406
Comorbidity of ADHD and dyslexia. 404
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 402
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. 399
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations 398
Adhd and human endogenous retroviruses 398
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. 398
Management of epilepsy in tuberous sclerosis complex 395
Website and Headache: Assessment of The Information Quality using the DISCERN Tool 395
Medical treatment in children with central nervous system malformations 393
Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations 392
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. 391
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families 391
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 390
Use of the DISCERN tool for evaluating web searches in childhood epilepsy. 389
Conceptual and methodological challenges for neuroimaging studies of autistic spectrum disorders. 388
Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity. 387
Cluster analysis of autistic patients based on principal pathogenetic components. 387
Candidate gene study of HOXB1 in autism spectrum disorder. 386
Current role of melatonin in pediatric neurology: Clinical recommendations 386
Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample 385
Methylphenidate-induced visual hallucinations. 384
Optical coherence tomography and infrared images of astrocytic hamartomas not revealed by funduscopy in tuberous sclerosis complex 384
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 384
Interstitial deletion of a proximal 3p: a clinically recognisable syndrome 383
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. 381
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 381
Long term clinical course of Tourette syndrome. 380
Child neurology: role of the International Association. 380
Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. 379
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 379
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 379
Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism 377
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 377
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. 376
Urinary p-cresol is elevated in small children with severe autism spectrum disorder. 375
Association of adenosine deaminase polymorphism with mild mental retardation 375
Hypnic headache in children. 374
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. 374
Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? 373
Epilepsy in tuberous sclerosis complex. 372
Two-loci ADA haplotypes in autistic disorder 372
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. 372
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 372
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 371
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 370
Long-term neurological outcome of a sextuplet pregnancy. 368
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 367
Effectiveness of community-based treatment on clinical outcome in children with autism spectrum disorders: An Italian prospective study. 367
Early-onset pure absence epilepsy: a distinct epileptic syndrome. 366
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. 366
Lack of association between MTHFR C677T and MTHFR A1298C genetic polymorphisms and mental retardation 365
Attention and executive functions profile in childhood absence epilepsy. 364
Lack of association between IDE genetic variability and Down's syndrome 363
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment 362
Late-onset epileptic spasms in children with Pallister-Killian syndrome: a report of two new cases and review of the electroclinical aspects. 361
Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations 360
Refractory absence seizures: An Italian multicenter retrospective study 360
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 357
Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD. 357
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 357
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 357
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome 356
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 355
Autism in tuberous sclerosis 353
MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? 353
Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities 352
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 352
Syndromic autism: Causes and pathogenetic pathways 351
Preterm birth and neurodevelopmental outcome: a review 351
Attention and executive functions profile in drug naive ADHD subtypes 349
The relationship between sleep and epilepsy: the effect on cognitive functioning in children. 349
Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference 349
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 349
Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems 348
Autism: evidence of association with adenosine deaminase genetic polymorphism 348
Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study 348
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 346
HERVs expression in autism spectrum disorders 345
De novo mosaic ring chromosome 18 in a child with mental retardation, epilepsy and immunological problems 344
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 344
Introduction. 344
Mild Wolf-Hirschhorn phenotype in a girl with unbalanced t(4p;12p) translocation without seizures. 343
Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report. 343
Autism and metabolic diseases 343
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 340
Altered anandamide degradation in attention-deficit/hyperactivity disorder 339
Totale 37.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.226 0 0 0 0 0 0 0 0 0 0 2.049 2.177
2019/202019.339 1.592 1.703 1.316 1.797 1.680 2.024 1.668 1.761 1.669 1.630 1.170 1.329
2020/202110.899 1.257 1.399 1.144 1.421 1.024 1.186 1.312 1.031 269 281 453 122
2021/20222.064 96 205 84 45 48 205 114 80 209 182 183 613
2022/20232.490 273 205 62 237 217 628 252 155 209 17 173 62
2023/2024771 135 42 55 26 76 211 65 48 33 45 35 0
Totale 68.196